Brief: Repare Therapeutics Reports Third Quarter 2020 Financial Results And Operational Highlights
Repare Therapeutics Inc RPTX.O :
* REPARE THERAPEUTICS REPORTS THIRD QUARTER 2020 FINANCIAL
RESULTS
AND OPERATIONAL HIGHLIGHTS
* Q3 LOSS PER SHARE $0.37
* Q3 EARNINGS PER SHARE ESTIMATE $-0.38 -- REFINITIV IBES
DATA
* CASH AND RESTRICTED CASH AS OF SEPTEMBER 30, 2020 WERE
$348.1
MILLION
Source text for Eikon: ID:nBw4pq5Zla
Further company coverage: RPTX.O
Recent news on Repare Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Repare Therapeutics Announces Acquisition Of Polθ ATPase Inhibitor, RP-3467, By Gilead Sciences For Up To $30 Million In Total Consideration
Brief: Repare Signs Support Agreements With Key Shareholders For Xenotherapeutics Deal
Repare Therapeutics Q2 net loss narrows to $16.7 mln